Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03416907 · ClinicalTrials.gov registry record · NA

Informed Consent Formats by Information Preference and Priority

A NA study, sponsored by Carnegie Mellon University.

Completed
Registry status
NA
Development phase
500
Enrollment target

NCT03416907: Completed NA study, sponsored by Carnegie Mellon University.

NCT03416907 is a NA study that has completed, run by Carnegie Mellon University. The registered enrollment target is 500 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03416907, a NA study, has completed, sponsored by Carnegie Mellon University.

COMPLETED
Registry status
NA
Development phase
500 participants
Enrollment target

Study Summary

This study will test whether different formats of medical informed consent documents can help improve understanding and confidence in decision-making for clinical trials. The study will be primarily run through an online survey.

Primary Outcome

Sum of correct answers (T/F) for any item relating to material that was rated as 50 or higher on impact on willingness to enroll in a previous study.

Interventions

  • BEHAVIORAL Original consent form
  • BEHAVIORAL Shortened consent form
  • BEHAVIORAL Reordered, shortened consent form
  • BEHAVIORAL Shortened consent form with a highlights box
  • BEHAVIORAL Interactive, shortened consent form

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2017-11-27
Est. Completion 2017-12-31
Phase NA
Carnegie Mellon University

37 total trials

What the finished NCT03416907 record still lists

NCT03416907 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower).

The record links to 0 conditions, and to 5 interventions - of which Original consent form is the first listed.

NCT03416907 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03416907 about?

NCT03416907 is a clinical study titled "Informed Consent Formats by Information Preference and Priority". This study will test whether different formats of medical informed consent documents can help improve understanding and confidence in decision-making for clinical trials. The study will be primarily run through an online survey.

What is the current status of trial NCT03416907?

This trial is currently completed. It is a NA study. The enrollment target is 500 participants. The study started on 2017-11-27. Estimated completion is 2017-12-31.

What interventions are being tested in trial NCT03416907?

The interventions under investigation include: Original consent form (BEHAVIORAL), Shortened consent form (BEHAVIORAL), Reordered, shortened consent form (BEHAVIORAL), Shortened consent form with a highlights box (BEHAVIORAL), Interactive, shortened consent form (BEHAVIORAL).

Who is sponsoring clinical trial NCT03416907?

This trial is sponsored by Carnegie Mellon University, which has 37 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03416907's enrollment target sits among peer trials

500 193rd of 2000 higher than 1,788 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001230 · 500 participants

    Host Response to Infection and Treatment in Filarial Diseases

  • NCT00001529 · 500 participants

    Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

  • NCT00697411 · 500 participants

    Study of Selected X-Linked Disorders: Aicardi Syndrome

  • NCT00903110 · 500 participants

    Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03416907, the US trial registry maintained by the National Library of Medicine. NCT03416907 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.